By contrast the frequencies of CCR6+IFNγ+ cells that can produce GM-CSF were significantly elevated in the CSF, as compared to the blood, although this was equally elevated in the OND and MS cohorts (Fig. 4B). The gene discussed is CCR6; the disease is myeloid sarcoma.